DOH Showcased “Malasakit at Aksyon” in the 1st face to face Policy Dialogue Since 2019

After three long years and five virtual policy dialogues, the Department of Health (DOH), its partner agencies and offices and the patient support groups and civil society organizations finally convened again face to face during the 16th Policy Dialogue on Universal Healthcare and Access to Medicines held on June 9, 2022 at Cocoon Boutique Hotel, Quezon City.

ASEAN Member States Virtually Assemble in the recent Drug Price Transparency Workshop

The Association of Southeast Asian Nations (ASEAN) Member States, comprising Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, and Vietnam, convened in a two-day online workshop to ensure fair prices and effective financing of medicines and health technologies with the aim to fortify health systems and to achieve wider Universal Health Coverage on April 6-7, 2022.

DOH’s 15th Patient Forum Highlights COVID Response, Accessibility of Health Commodities

The Department of Health (DOH) on March 30, 2022 convened patient groups and civil society organizations (CSOs) to discuss updates on the national government’s COVID-19 response, vaccination program rollout, and the ongoing initiatives to provide Filipinos better access to pharmaceutical commodities and healthcare services during the virtual 15th Policy Dialogue on Universal Health Care (UHC) and Access to Medicines with  theme “Gamot Para sa Lahat, Siguruhing Sasapat”.

DOH Announces Full Implementation of Drug Price Caps with Executive Order No. 155

The Department of Health (DOH) announces the full implementation of drug price caps starting March 23, 2022 through Executive Order (EO) No. 155 signed by President Rodrigo Duterte. This brings the total number of drugs with maximum drug retail price to 121 molecules or 204 drug formulas, following the first round of price regulation implemented in June 2020 with the signing of EO No. 104 which covered 87 molecules.